Clinical Trial Update: The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects [Phase 2, Phase 3]

View source ↗

Summary

Update on a trial using autologous bone marrow mesenchymal stem cells to treat articular cartilage defects. The study is listed as Phase 2 and Phase 3 with stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect
• Osteoarthritis
• Osteochondral Defect

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Cairo University | Conditions: Degenerative Arthritis, Chondral Defects | Phase 2, Phase 3 | Status: UNKNOWN